Johanne I Weberpals (J I Weberpals)

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

A Kulkarni, N M Andrews Wright, A N Forget, T Ramsay, R Mallick, Johanne I Weberpals
Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins. Cancer medicine (2023)
Johanne I Weberpals, Trevor J Pugh, Paola Marco-Casanova, Glenwood D Goss, Natalie Andrews Wright, Prisni Rath, Jonathon Torchia, Alexander Fortuna, Gemma N Jones, Martine P Roudier, Laurence Bernard, Bryan Lo, Dax Torti, Alberto Leon, Kayla Marsh, Darren Hodgson, Marc Duciaume, William J Howat, Natalia Lukashchuk, Stanley E Lazic, Doreen Whelan, Harmanjatinder S Sekhon
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer. Cancer medicine 10 (9) (2021)
Ana Oaknin, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew R Clamp, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O'Malley, Deborah K Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Jonathan A Ledermann, Robert L Coleman
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety. Cancer medicine 10 (20) (2021)

Johanne I Weberpals.css-eqlu8i{font-size:small;padding-left:4px;} (J I Weberpals)